GASTROESOPHAGEAL CANCER (GC)
Clinical trials for GASTROESOPHAGEAL CANCER (GC) explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL CANCER (GC) trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL CANCER (GC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets Hard-to-Treat cancers with rare gene deletion
Disease control Recruiting nowThis early-stage study tests a new drug called IDE892, alone or with other medicines, in people with advanced solid tumors that lack a gene called MTAP. The goal is to see if the drug is safe and can shrink tumors. About 260 adults with certain cancers (like lung, stomach, bladde…
Matched conditions: GASTROESOPHAGEAL CANCER (GC)
Phase: PHASE1 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New drug CTX-10726 tested in patients with advanced cancers
Disease control Recruiting nowThis study is testing a new drug called CTX-10726 in people with advanced cancers (stomach, liver, endometrial, or kidney) that have not responded to standard treatments. The main goal is to check the drug's safety and find the best dose. About 70 participants will receive the dr…
Matched conditions: GASTROESOPHAGEAL CANCER (GC)
Phase: PHASE1 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated May 22, 2026 13:50 UTC